Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Anell

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Lakartidningen|August 20, 2008
[Care Choice on its way in primary health care. Big differences between the models and high needs for development]Anders Anell
Health Economics, Policy, and Law|August 13, 2010
Choice and privatisation in Swedish primary careAnders Anell
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committeesAnders Anell
Health Policy (Amsterdam, Netherlands)|November 22, 2005
Deregulating the pharmacy market: the case of Iceland and NorwayAnders Anell
Lakartidningen|April 23, 2004
[Primary health care--preserve conflicts or patient-centered care?]Anders Anell
Health Economics|September 15, 2005
Swedish healthcare under pressureAnders Anell
The New England Journal of Medicine|January 1, 2015
The public-private pendulum--patient choice and equity in SwedenAnders Anell
BMC Health Services Research|June 14, 2023
Better with GPs as managers? - Variation in perceptions of feedback messages, goal-clarity and performance across manager´s in Swedish primary careAnders Anell, Anna Glenngård
Health Policy (Amsterdam, Netherlands)|July 28, 2005
The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectivenessSandra Jansson, Anders Anell
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 22, 2005
Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?Anders Anell, Ulf Persson
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Lakartidningen|August 20, 2008
[Care Choice on its way in primary health care. Big differences between the models and high needs for development]Anders Anell
Health Economics, Policy, and Law|August 13, 2010
Choice and privatisation in Swedish primary careAnders Anell
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Priority setting for pharmaceuticals. The use of health economic evidence by reimbursement and clinical guidance committeesAnders Anell
Health Policy (Amsterdam, Netherlands)|November 22, 2005
Deregulating the pharmacy market: the case of Iceland and NorwayAnders Anell
Lakartidningen|April 23, 2004
[Primary health care--preserve conflicts or patient-centered care?]Anders Anell
Health Economics|September 15, 2005
Swedish healthcare under pressureAnders Anell
The New England Journal of Medicine|January 1, 2015
The public-private pendulum--patient choice and equity in SwedenAnders Anell
BMC Health Services Research|June 14, 2023
Better with GPs as managers? - Variation in perceptions of feedback messages, goal-clarity and performance across manager´s in Swedish primary careAnders Anell, Anna Glenngård
Health Policy (Amsterdam, Netherlands)|July 28, 2005
The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectivenessSandra Jansson, Anders Anell
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 22, 2005
Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?Anders Anell, Ulf Persson
Pageof 5